Earnings Release: Wednesday, May 13, 2026, Before Market OpensConference Call and Webcast: Wednesday, May 13, 2026, at 8:30 a.m. ET MONACO, May 08, 2026 (GLOBE NEWSWIRE) — Costamare Bulkers Holdings Limited (NYSE:CMDB) (“Costamare Bulkers” or the “Company”), announced today that it will release its results for the first quarter ended March 31, 2026 before the market opens in New York on May 13, 2026. Conference Call Details: On Wednesday, May 13, 2026 at 8:30 a.m. ET, Costamare Bulkers’ management team will hold a conference call to discuss the financial results. Participants should dial into the call 10 minutes before the scheduled time using the following numbers: 1-844-887-9405 (from the US) or +1-412-317-9258 (from outside the US). Please quote “Costamare Bulkers”. A replay of the conference call will be available...

ABU DHABI, United Arab Emirates, May 08, 2026 (GLOBE NEWSWIRE) — Micropolis AI Robotics (NYSE: MCRP) (“Micropolis” or the “Company”), a leading UAE-based developer of autonomous mobile robots and AI-enabled systems, concluded Make it in the Emirates 2026 with strong national recognition, major commercial momentum, and one of the event’s defining advanced technology showcases.The Company was featured during the opening ceremony as the event’s standout UAE success story in the technology sector, with the Company’s growth journey and technological achievements highlighted before senior UAE leadership, including His Highness Sheikh Mansour bin Zayed Al Nahyan, Vice President, Deputy Prime Minister and Chairman of the Presidential Court, and His Excellency Dr. Sultan Ahmed Al Jaber, Minister of Industry and Advanced Technology, Managing...

Jena, Germany, May 08, 2026 (GLOBE NEWSWIRE) —  InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, announced today that it has completed its underwritten offering of 75,000,000 ordinary shares of the Company at an offering price of $2.00 per ordinary share. The aggregate gross proceeds from the offering were $150 million, before deducting the underwriting discount and offering expenses. The Company intends to use the net proceeds from the offering to advance its pipeline activities and for working capital and general corporate purposes. The financing included participation from new and existing investors, including TCGX, a large healthcare-dedicated fund, Farallon Capital Management, Sirenia Capital Management LP, Columbia Threadneedle...

HONG KONG, May 08, 2026 (GLOBE NEWSWIRE) — 3 E Network Technology Group Limited (Nasdaq: MASK) (the “Company” or “3 E Network”), a business-to-business (“B2B”) information technology (“IT”) business solutions provider committed to becoming a next-generation artificial intelligence (“AI”) infrastructure solutions provider, today announced the advancement of a proactive capital-raising strategy designed to robustly fund its recently unveiled semiconductor and compute infrastructure blueprint. The Company has secured a $1.3 million convertible note agreement with an institutional investor. This capital, along with ongoing financing initiatives, will directly fuel the “Vertically Integrated Ecosystem” strategy led by Vice President Mr. Siyang Hu, accelerating the Company’s evolution from a system integrator to a developer of proprietary...

Recognition follows the introduction of 16 commodity futures benchmarks and growing activity across Abaxx Exchange markets TORONTO, May 08, 2026 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE:ABXX)(OTCQX:ABXXF) (“Abaxx” or the “Company”), a financial software and market infrastructure company and indirect majority shareholder of Abaxx Singapore Pte Ltd. (“Abaxx Singapore”), the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), today announced that Abaxx Exchange has been named Newcomer of the Year by Energy Risk at the 2026 Energy Risk Awards. Risk.net’s Energy Risk Awards recognize excellence across global energy and commodity markets. The Newcomer of the Year award recognizes emerging companies, or established firms entering new markets, that have demonstrated growth,...

Plenary session at AANS underscores REYOBIQ’s potential as a differentiated targeted radiotherapeutic platform for CNS cancers HOUSTON, Texas, May 08, 2026 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous system (CNS) cancers, today announces a plenary session reviewing key clinical and translational data, including the Phase 1 ReSPECT-LM trial of REYOBIQ™ (rhenium Re186 obisbemeda) was presented at the 2026 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting taking place May 1-4, 2026 in San Antonio, Texas. “This oral plenary session, which reviewed data collected to date, and included an overview of the ReSPECT-LM single dose escalation study,...

PMA submission targeted for May 29, 2026 in alignment with FDA Vantive commits to additional funding support ahead of PMA acceptance milestoneTORONTO, May 08, 2026 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the first quarter ended March 31, 2026 and provided a corporate update. The first quarter of 2026 marked continued progress across regulatory, clinical and commercial readiness initiatives as the Company advances toward submission of its U.S. Food and Drug Administration (“FDA”) Premarket Approval (“PMA”) application for Toraymyxin™ (“PMX”). During the quarter and subsequent to quarter-end, Spectral further strengthened the clinical and scientific...

HOUSTON, May 08, 2026 (GLOBE NEWSWIRE) — Plains All American Pipeline, L.P. (Nasdaq: PAA) and Plains GP Holdings (Nasdaq: PAGP) today reported first-quarter 2026 results and raised full-year 2026 Adjusted EBITDA Guidance. First-Quarter 2026 ResultsFirst-quarter Net income attributable to PAA of $152 million and Net cash provided by operating activities of $418 million Delivered first-quarter Adjusted EBITDA attributable to PAA of $730 million Pro forma leverage ratio of 4.1x at quarter-end; expect to return toward the midpoint of the target range of 3.25 to 3.75x following closing of the NGL divestiture and migrating toward lower-end of the range by year-end Paid a quarterly cash distribution of $0.4175 per unit ($1.67 per unit annualized), representing a current distribution yield of ~7.5%2026 Updated OutlookIncreasing midpoint...

Live today at XOCash.com, XO Cash is a stablecoin for AI agents; its SDK lets users grant any agent its own wallet, funded from their Exodus Pay balance, while keeping the keys OMAHA, Neb., May 08, 2026 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) (“Exodus” or the “Company”) today launched XO Cash, the first stablecoin purpose-built for AI agents and the agentic economy. Built on Solana and developed in partnership with MoonPay, XO Cash comes with AgentKit, an agent SDK so developers can issue any agent its own wallet with a single API call. Agents spend directly from their Exodus Pay balance, so an agent can spend with the same speed and convenience as Exodus Pay itself, and the agent never holds or manages a key. Users set the rules for each agent, including daily limits, per-transaction...